Chelation Therapy Provides No Benefit Post-MI : vimarsana.co

Chelation therapy to remove potentially toxic levels of lead was not associated with a reduction in CV events in post-MI patients with diabetes in the TACT2 trial.

Related Keywords

Florida , United States , Canada , Massachusetts , Fort Myers , Miami , Boston , America , Richard Chazal , Suzanne Baron , Vascular Institute , Lee Memorial Health System , Mount Sinai Medical Center , Gervasio Lamas , American College , Annual Scientific Session , Massachusetts General Hospital , North America , Cv Risk , Cardiovascular Risk , V Risk Factors , Cardiovascular Risk Factors , Cardiovascular Risk Management , Toxicology , Toxicity , Poisoning , Toxins , Heavy Metal Toxicity , Environmental Medicine , Environmental Health , Blood , Chelation Therapy , Angina , Angina Pectoris , Myocardial Infarction , Stroke Cerebrovascular Accident Cva , Healthcare And Medical Technology ,